Silo Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.92	3.91	3.52	11.37	9.84	1.13
Short-Term Investments	1.95	3.17	4.14	0	0.42	0
Cash & Short-Term Investments	5.87	7.08	7.67	11.37	10.26	1.13
Cash Growth	-26.81%	-7.63%	-32.58%	10.85%	808.83%	831.59%
Accounts Receivable	0.01	0	0	0	0	-
Receivables	0.01	0	0	0.07	0	0.02
Prepaid Expenses	0.18	0.03	0.01	0.12	0.06	0.13
Other Current Assets	0.11	0.01	0.01	0.02	0.08	0.14
Total Current Assets	6.16	7.11	7.68	11.57	10.4	1.43
Other Intangible Assets	0.22	0.24	-	-	-	-
Long-Term Accounts Receivable	-	0.01	0.01	0.01	0.01	-
Long-Term Deferred Charges	-	0.05	0.06	0.06	0.02	-
Total Assets	6.38	7.41	7.75	11.64	10.49	1.43
Accounts Payable	0.64	1.58	0.7	0.22	0.42	0.13
Accrued Expenses	-	-	-	0.14	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.01
Current Unearned Revenue	0.07	0.07	0.07	0.07	0.07	-
Total Current Liabilities	0.71	1.66	0.78	0.44	0.49	0.14
Long-Term Debt	-	-	-	-	-	0
Long-Term Unearned Revenue	0.67	0.72	0.79	0.87	0.94	-
Total Liabilities	1.38	2.38	1.57	1.3	1.43	0.15
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	23.61	20.3	17.53	17.51	12.32	7.03
Retained Earnings	-18.61	-15.26	-10.87	-7.17	-3.26	-5.76
Treasury Stock	-	-	-0.47	-	-	-
Comprehensive Income & Other	0.01	0	-0.01	-	-	-
Total Common Equity	5.01	5.03	6.18	10.34	9.06	1.28
Shareholders' Equity	5.01	5.03	6.18	10.34	9.06	1.28
Total Liabilities & Equity	6.38	7.41	7.75	11.64	10.49	1.43
Total Debt	-	-	-	-	-	0.02
Net Cash (Debt)	5.87	7.08	7.67	11.37	10.26	1.11
Net Cash Growth	-26.81%	-7.63%	-32.58%	10.85%	824.31%	1772.23%
Net Cash Per Share	0.95	1.92	2.49	4.98	5.35	0.84
Filing Date Shares Outstanding	13.32	4.48	2.84	3.16	1.97	1.7
Total Common Shares Outstanding	10.46	4.48	2.91	3.16	1.97	1.7
Working Capital	5.46	5.46	6.91	11.14	9.91	1.28
Book Value Per Share	0.48	1.12	2.13	3.27	4.59	0.75
Tangible Book Value	4.79	4.79	6.18	10.34	9.06	1.28
Tangible Book Value Per Share	0.46	1.07	2.13	3.27	4.59	0.75

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q